Nanjing Leads Biolabs has announced that China’s Center for Drug Evaluation has accepted the New Drug Application ...
CureGene has dosed the first participant in an Australian Phase I clinical trial of CG-0416, an investigational oral liv...
CStone Pharmaceuticals has received approval from China’s National Medical Products Administration to initiate cli...
Telix Pharmaceuticals has reported continued progress across its radiopharmaceutical imaging and therapeutic pipeline du...
Brii Biosciences has advanced its internally developed mRNA therapeutic cancer vaccine BRII-5395 into clinical evaluatio...
Brown University Health and Arcamyra Therapeutics are preparing to launch a Phase I clinical trial of ACM-CpG in patient...
CanSino Biologics has announced that China’s National Medical Products Administration has accepted the New Drug Ap...
Everest Medicines has announced that China’s National Medical Products Administration has accepted the Biologics L...
The 2026 CDISC China Interchange has brought clinical research data specialists and industry stakeholders together in Sh...
Ascletis Pharma has initiated two Phase I studies in the United States evaluating investigational once-monthly injectabl...
A Phase III clinical trial has found that adding high-dose vitamin D3 to chemotherapy and bevacizumab does not improve p...
Shanghai Ark Biopharmaceutical, or ArkBio, has completed dosing across all healthy-volunteer cohorts in an Australian Ph...
Harbour BioMed and Kelun-Biotech have received approval from China’s National Medical Products Administration to b...
Kelun-Biotech has received approval from the Center for Drug Evaluation of China’s National Medical Products Admin...
How would you assess the current state of Thailand's life sciences ecosystem, and what key developments have stood out o...
The Singapore Clinical Research Institute (SCRI) convened its Clinical Trials Symposium 2026 on 30th July, bringing toge...
BioLineRx and Hemispherian will present preclinical data on GLIX1 at the 2026 European Society for Medical Oncology Annu...
Akeso has launched a Phase II clinical study in the United States evaluating a cadonilimab-based combination regimen for...
HUYABIO International has reported statistically significant and clinically meaningful topline Phase 3 results for HBI-8...
Insmed has reported positive 12-month data from the ongoing open-label extension study of treprostinil palmitil inhalati...
Maxona Pharmaceuticals has received U.S. FDA clearance of its Investigational New Drug application for a Phase 2 clinica...
Lakewood-Amedex Biotherapeutics has announced preclinical safety data supporting clinical dose selection for its upcomin...
As BioSpectrum Asia reports on the ground from BIO Asia–Taiwan 2026, being held from July 15–19 in T...
Lynk Pharmaceuticals has completed patient enrolment in its Phase III clinical trial of zemprocitinib capsules for activ...
Kelun-Biotech has reported positive Phase III results for sacituzumab tirumotecan, also known as sac-TMT or SKB264/MK-28...
